Tiaa Fsb decreased its position in Colgate-Palmolive (NYSE: CL – Get Rating) by 0.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 66,875 shares of the company stock after selling 210 shares during the period. Tiaa Fsb’s holdings in Colgate-Palmolive were worth $ 5,071,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Colgate-Palmolive by 79.8% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 263,523 shares of the company stock valued at $ 22,489,000 after buying an additional 116,999 shares during the last quarter. Capital Investment Advisors LLC raised its stake in shares of Colgate-Palmolive by 5.1% during the 4th quarter. Capital Investment Advisors LLC now owns 9,282 shares of the company stock valued at $ 792,000 after buying an additional 452 shares during the last quarter. US Asset Management LLC purchased a new position in shares of Colgate-Palmolive during the 1st quarter valued at about $ 39,000. CWM LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $ 23,277,000. Finally, Beacon Investment Advisory Services Inc. raised its stake in shares of Colgate-Palmolive by 1.5% during the 4th quarter. Beacon Investment Advisory Services Inc. now owns 31,234 shares of the company stock valued at $ 2,666,000 after buying an additional 474 shares during the last quarter. Institutional investors own 78.12% of the company stock.
CL has been the subject of a number of recent research reports. The Goldman Sachs Group reduced their price target on Colgate-Palmolive from $ 104.00 to $ 95.00 in a research note on Tuesday, March 29th. Barclays dropped their target price on Colgate-Palmolive from $ 77.00 to $ 71.00 and set an “equal weight” rating on the stock in a research report on Monday, May 23rd. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $ 86.00 to $ 81.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 30th. Raymond James started coverage on Colgate-Palmolive in a research report on Thursday, April 7th. They set a “market perform” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Colgate-Palmolive from $ 91.00 to $ 88.00 in a research report on Monday, May 2nd. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $ 83.92.
CL stock opened at $ 80.38 on Friday. The company has a current ratio of 1.09, a quick ratio of 0.67 and a debt-to-equity ratio of 10.42. Colgate-Palmolive has a 12-month low of $ 72.20 and a 12-month high of $ 85.61. The stock has a market cap of $ 67.35 billion, a price-to-earnings ratio of 33.21, a PEG ratio of 5.26 and a beta of 0.56. The business’s 50-day moving average is $ 77.78 and its 200 day moving average is $ 79.12.
Colgate-Palmolive (NYSE: CL – Get Rating) last issued its earnings results on Friday, April 29th. The company reported $ 0.74 earnings per share for the quarter, hitting the consensus estimate of $ 0.74. The business had revenue of $ 4.40 billion for the quarter, compared to analysts’ expectations of $ 4.40 billion. Colgate-Palmolive had a return on equity of 296.77% and a net margin of 11.70%. The business’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $ 0.80 EPS. As a group, equities analysts forecast that Colgate-Palmolive will post 3.05 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, August 15th. Stockholders of record on Thursday, July 21st will be issued a dividend of $ 0.47 per share. This represents a $ 1.88 annualized dividend and a dividend yield of 2.34%. The ex-dividend date of this dividend is Wednesday, July 20th. Colgate-Palmolive’s dividend payout ratio is currently 77.69%.
Colgate-Palmolive announced that its board has approved a stock buyback plan on Thursday, March 10th that permits the company to buyback $ 5.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 8.1% of its shares through open market purchases. Shares buyback plans are generally an indication that the company board believes its shares are undervalued.
In other news, insider John W. Kooyman sold 19,683 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $ 78.49, for a total transaction of $ 1,544,918.67. Following the sale, the insider now owns 7,007 shares of the company stock, valued at approximately $ 549,979.43. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Philip G. Shotts sold 10,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $ 78.52, for a total transaction of $ 785,200.00. Following the sale, the vice president now directly owns 46,094 shares in the company, valued at approximately $ 3,619,300.88. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 79,683 shares of company stock worth $ 6,297,119. Insiders own 0.32% of the company stock.
About Colgate-Palmolive: (Get Rating)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More:
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE: CL – Get Rating).
Receive News & Ratings for Colgate-Palmolive Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.
.